Skip to main content
Top
Published in: Clinical Reviews in Allergy & Immunology 1/2012

01-02-2012

Animal Models in Autoimmune Diseases: Lessons Learned from Mouse Models for Sjögren’s Syndrome

Authors: Byung Ha Lee, Adrienne E. Gauna, Kaleb M. Pauley, Yun-Jong Park, Seunghee Cha

Published in: Clinical Reviews in Allergy & Immunology | Issue 1/2012

Login to get access

Abstract

The mouse model is the one of the most frequently used and well-established animal models, and is currently used in many research areas. To date, various mouse models have been utilized to elucidate underlying causes of multifactorial autoimmune conditions, including pathological immune components and specific signaling pathways. This review summarizes the more recent mouse models for Sjögren’s syndrome, a systemic autoimmune disease characterized by lymphocytic infiltration in the exocrine glands, such as the salivary and lacrimal glands, and loss of secretory function, resulting in dry mouth and dry eyes in patients. Although every Sjögren’s syndrome mouse model resembles the major symptoms or phenotypes of Sjögren’s syndrome conditions in humans, the characteristics of each model are variable. Moreover, to date, there is no single mouse model that can completely replicate the human conditions. However, unique features of each mouse model provide insights into the roles of potential etiological and immunological factors in the development and progression of Sjögren’s syndrome. Here, we will overview the Sjögren’s syndrome mouse models. Lessons from these mouse models will aid us to understand underlying immune dysregulation in autoimmune diseases in general, and will guide us to direct future research towards appropriate diagnostic and therapeutic strategies.
Literature
1.
go back to reference Taebel DW (1990) The importance of animals in biomedical research. Wis Med J 89(155):158 Taebel DW (1990) The importance of animals in biomedical research. Wis Med J 89(155):158
2.
go back to reference Wolf SD, Dittel BN, Hardardottir F, Janeway CA Jr (1996) Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J exp med 184:2271–2278PubMedCrossRef Wolf SD, Dittel BN, Hardardottir F, Janeway CA Jr (1996) Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J exp med 184:2271–2278PubMedCrossRef
3.
go back to reference Bolstad AI, Wassmuth R, Haga HJ, Jonsson R (2001) HLA markers and clinical characteristics in Caucasians with primary Sjögren’s syndrome. J Rheumatol 28:1554–1562PubMed Bolstad AI, Wassmuth R, Haga HJ, Jonsson R (2001) HLA markers and clinical characteristics in Caucasians with primary Sjögren’s syndrome. J Rheumatol 28:1554–1562PubMed
4.
go back to reference Perez P, Anaya JM, Aguilera S et al (2009) Gene expression and chromosomal location for susceptibility to Sjögren’s syndrome. J Autoimmun 33:99–108PubMedCrossRef Perez P, Anaya JM, Aguilera S et al (2009) Gene expression and chromosomal location for susceptibility to Sjögren’s syndrome. J Autoimmun 33:99–108PubMedCrossRef
5.
go back to reference Hu Y, Nakagawa Y, Purushotham KR, Humphreys-Beher MG (1992) Functional changes in salivary glands of autoimmune disease-prone NOD mice. Am J Physiol 263:E607–E614PubMed Hu Y, Nakagawa Y, Purushotham KR, Humphreys-Beher MG (1992) Functional changes in salivary glands of autoimmune disease-prone NOD mice. Am J Physiol 263:E607–E614PubMed
6.
go back to reference Humphreys-Beher MG (1996) Animal models for autoimmune disease-associated xerostomia and xerophthalmia. Adv Dent Res 10:73–75PubMedCrossRef Humphreys-Beher MG (1996) Animal models for autoimmune disease-associated xerostomia and xerophthalmia. Adv Dent Res 10:73–75PubMedCrossRef
7.
go back to reference Delaleu N, Immervoll H, Cornelius J, Jonsson R (2008) Biomarker profiles in serum and saliva of experimental Sjögren’s syndrome: associations with specific autoimmune manifestations. Arthritis Res Ther 10:R22PubMedCrossRef Delaleu N, Immervoll H, Cornelius J, Jonsson R (2008) Biomarker profiles in serum and saliva of experimental Sjögren’s syndrome: associations with specific autoimmune manifestations. Arthritis Res Ther 10:R22PubMedCrossRef
8.
go back to reference Roescher N, Vosters JL, Yin H, Illei GG, Tak PP, Chiorini JA (2011) Effect of soluble ICAM-1 on a Sjögren’s syndrome-like phenotype in NOD mice is disease stage dependent. PLoS One 6:e19962PubMedCrossRef Roescher N, Vosters JL, Yin H, Illei GG, Tak PP, Chiorini JA (2011) Effect of soluble ICAM-1 on a Sjögren’s syndrome-like phenotype in NOD mice is disease stage dependent. PLoS One 6:e19962PubMedCrossRef
9.
go back to reference Brayer JB, Cha S, Nagashima H et al (2001) IL-4-dependent effector phase in autoimmune exocrinopathy as defined by the NOD.IL-4-gene knockout mouse model of Sjögren’s syndrome. Scand J Immunol 54:133–140PubMedCrossRef Brayer JB, Cha S, Nagashima H et al (2001) IL-4-dependent effector phase in autoimmune exocrinopathy as defined by the NOD.IL-4-gene knockout mouse model of Sjögren’s syndrome. Scand J Immunol 54:133–140PubMedCrossRef
10.
go back to reference Cha S, Brayer J, Gao J et al (2004) A dual role for interferon-gamma in the pathogenesis of Sjögren’s syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse. Scand J Immunol 60:552–565PubMedCrossRef Cha S, Brayer J, Gao J et al (2004) A dual role for interferon-gamma in the pathogenesis of Sjögren’s syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse. Scand J Immunol 60:552–565PubMedCrossRef
11.
go back to reference Brayer J, Lowry J, Cha S et al (2000) Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjögren’s syndrome-like autoimmune exocrinopathy. J Rheumatol 27:1896–1904PubMed Brayer J, Lowry J, Cha S et al (2000) Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjögren’s syndrome-like autoimmune exocrinopathy. J Rheumatol 27:1896–1904PubMed
12.
go back to reference Cha S, Nagashima H, Brown VB, Peck AB, Humphreys-Beher MG (2002) Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren’s syndrome) on a healthy murine background. Arthritis Rheum 46:1390–1398PubMedCrossRef Cha S, Nagashima H, Brown VB, Peck AB, Humphreys-Beher MG (2002) Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren’s syndrome) on a healthy murine background. Arthritis Rheum 46:1390–1398PubMedCrossRef
13.
go back to reference Lee BH, Tudares MA, Nguyen CQ (2009) Sjögren’s syndrome: an old tale with a new twist. Arch Immunol Ther Exp 57:57–66CrossRef Lee BH, Tudares MA, Nguyen CQ (2009) Sjögren’s syndrome: an old tale with a new twist. Arch Immunol Ther Exp 57:57–66CrossRef
14.
go back to reference Doyle ME, Boggs L, Attia R et al (2007) Autoimmune dacryoadenitis of NOD/LtJ mice and its subsequent effects on tear protein composition. Am J Pathol 171:1224–1236PubMedCrossRef Doyle ME, Boggs L, Attia R et al (2007) Autoimmune dacryoadenitis of NOD/LtJ mice and its subsequent effects on tear protein composition. Am J Pathol 171:1224–1236PubMedCrossRef
15.
go back to reference Nguyen C, Cornelius J, Singson E, Killedar S, Cha S, Peck AB (2006) Role of complement and B lymphocytes in Sjögren’s syndrome-like autoimmune exocrinopathy of NOD.B10-H2b mice. Mol Immunol 43:1332–1339PubMedCrossRef Nguyen C, Cornelius J, Singson E, Killedar S, Cha S, Peck AB (2006) Role of complement and B lymphocytes in Sjögren’s syndrome-like autoimmune exocrinopathy of NOD.B10-H2b mice. Mol Immunol 43:1332–1339PubMedCrossRef
16.
go back to reference Killedar SJ, Killedar SY, Eckenrode SE et al (2006) Early pathogenic events associated with Sjögren’s syndrome (SjS)-like disease of the NOD mouse using microarray analysis. Lab Invest 86:1243–1260PubMedCrossRef Killedar SJ, Killedar SY, Eckenrode SE et al (2006) Early pathogenic events associated with Sjögren’s syndrome (SjS)-like disease of the NOD mouse using microarray analysis. Lab Invest 86:1243–1260PubMedCrossRef
17.
go back to reference Cha S, Van Blockland SC, Versnel MA et al (2001) Abnormal organogenesis in salivary gland development may initiate adult onset of autoimmune exocrinopathy. Exp Clin Immunogenet 18:143–160PubMedCrossRef Cha S, Van Blockland SC, Versnel MA et al (2001) Abnormal organogenesis in salivary gland development may initiate adult onset of autoimmune exocrinopathy. Exp Clin Immunogenet 18:143–160PubMedCrossRef
18.
go back to reference Bulosan M, Pauley KM, Yo K et al (2009) Inflammatory caspases are critical for enhanced cell death in the target tissue of Sjögren’s syndrome before disease onset. Immunol Cell Biol 87:81–90PubMedCrossRef Bulosan M, Pauley KM, Yo K et al (2009) Inflammatory caspases are critical for enhanced cell death in the target tissue of Sjögren’s syndrome before disease onset. Immunol Cell Biol 87:81–90PubMedCrossRef
19.
go back to reference Ridgway WM, Peterson LB, Todd JA et al (2008) Gene-gene interactions in the NOD mouse model of type 1 diabetes. Adv Immunol 100:151–175PubMedCrossRef Ridgway WM, Peterson LB, Todd JA et al (2008) Gene-gene interactions in the NOD mouse model of type 1 diabetes. Adv Immunol 100:151–175PubMedCrossRef
20.
go back to reference Stojanovich L, Marisavljevich D (2008) Stress as a trigger of autoimmune disease. Autoimmun Rev 7:209–213PubMedCrossRef Stojanovich L, Marisavljevich D (2008) Stress as a trigger of autoimmune disease. Autoimmun Rev 7:209–213PubMedCrossRef
21.
go back to reference Ishimaru N, Arakaki R, Watanabe M, Kobayashi M, Miyazaki K, Hayashi Y (2003) Development of autoimmune exocrinopathy resembling Sjögren’s syndrome in estrogen-deficient mice of healthy background. Am J Pathol 163:1481–1490PubMedCrossRef Ishimaru N, Arakaki R, Watanabe M, Kobayashi M, Miyazaki K, Hayashi Y (2003) Development of autoimmune exocrinopathy resembling Sjögren’s syndrome in estrogen-deficient mice of healthy background. Am J Pathol 163:1481–1490PubMedCrossRef
22.
go back to reference Ohyama Y, Carroll VA, Deshmukh U, Gaskin F, Brown MG, Fu SM (2006) Severe focal sialadenitis and dacryoadenitis in NZM2328 mice induced by MCMV: a novel model for human Sjögren’s syndrome. J Immunol 177:7391–7397PubMed Ohyama Y, Carroll VA, Deshmukh U, Gaskin F, Brown MG, Fu SM (2006) Severe focal sialadenitis and dacryoadenitis in NZM2328 mice induced by MCMV: a novel model for human Sjögren’s syndrome. J Immunol 177:7391–7397PubMed
23.
go back to reference Lagenaur LA, Manning WC, Vieira J, Martens CL, Mocarski ES (1994) Structure and function of the murine cytomegalovirus sgg1 gene: a determinant of viral growth in salivary gland acinar cells. J Virol 68:7717–7727PubMed Lagenaur LA, Manning WC, Vieira J, Martens CL, Mocarski ES (1994) Structure and function of the murine cytomegalovirus sgg1 gene: a determinant of viral growth in salivary gland acinar cells. J Virol 68:7717–7727PubMed
24.
go back to reference Cavanaugh VJ, Deng Y, Birkenbach MP, Slater JS, Campbell AE (2003) Vigorous innate and virus-specific cytotoxic T-lymphocyte responses to murine cytomegalovirus in the submaxillary salivary gland. J Virol 77:1703–1717PubMedCrossRef Cavanaugh VJ, Deng Y, Birkenbach MP, Slater JS, Campbell AE (2003) Vigorous innate and virus-specific cytotoxic T-lymphocyte responses to murine cytomegalovirus in the submaxillary salivary gland. J Virol 77:1703–1717PubMedCrossRef
25.
go back to reference Fleck M, Kern ER, Zhou T, Lang B, Mountz JD (1998) Murine cytomegalovirus induces a Sjögren’s syndrome-like disease in C57Bl/6-lpr/lpr mice. Arthritis rheum 41:2175–2184PubMedCrossRef Fleck M, Kern ER, Zhou T, Lang B, Mountz JD (1998) Murine cytomegalovirus induces a Sjögren’s syndrome-like disease in C57Bl/6-lpr/lpr mice. Arthritis rheum 41:2175–2184PubMedCrossRef
26.
go back to reference Skarstein K, Nerland AH, Eidsheim M, Mountz JD, Jonsson R (1997) Lymphoid cell accumulation in salivary glands of autoimmune MRL mice can be due to impaired apoptosis. Scand J Immunol 46:373–378PubMedCrossRef Skarstein K, Nerland AH, Eidsheim M, Mountz JD, Jonsson R (1997) Lymphoid cell accumulation in salivary glands of autoimmune MRL mice can be due to impaired apoptosis. Scand J Immunol 46:373–378PubMedCrossRef
27.
go back to reference Ichikawa Y, Arimori K, Yoshida M et al (1995) Abnormal expression of apoptosis-related antigens, Fas and bcl-2, on circulating T-lymphocyte subsets in primary Sjögren’s syndrome. Clin Exp Rheumatol 13:307–313PubMed Ichikawa Y, Arimori K, Yoshida M et al (1995) Abnormal expression of apoptosis-related antigens, Fas and bcl-2, on circulating T-lymphocyte subsets in primary Sjögren’s syndrome. Clin Exp Rheumatol 13:307–313PubMed
28.
go back to reference Fleck M, Zhang HG, Kern ER, Hsu HC, Muller-Ladner U, Mountz JD (2001) Treatment of chronic sialadenitis in a murine model of Sjögren’s syndrome by local fasL gene transfer. Arthritis rheum 44:964–973PubMedCrossRef Fleck M, Zhang HG, Kern ER, Hsu HC, Muller-Ladner U, Mountz JD (2001) Treatment of chronic sialadenitis in a murine model of Sjögren’s syndrome by local fasL gene transfer. Arthritis rheum 44:964–973PubMedCrossRef
30.
go back to reference Ishimaru N, Saegusa K, Yanagi K, Haneji N, Saito I, Hayashi Y (1999) Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjögren’s syndrome through fas-mediated apoptosis. Am J Pathol 155:173–181PubMedCrossRef Ishimaru N, Saegusa K, Yanagi K, Haneji N, Saito I, Hayashi Y (1999) Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjögren’s syndrome through fas-mediated apoptosis. Am J Pathol 155:173–181PubMedCrossRef
31.
go back to reference Kassi E, Moutsatsou P, Sekeris CE, Moutsopoulos HM, Manoussakis MN (2003) Oestrogen receptors in cultured epithelial cells from salivary glands of Sjögren’s syndrome patients. Rheumatology (Oxford) 42:1120–1122CrossRef Kassi E, Moutsatsou P, Sekeris CE, Moutsopoulos HM, Manoussakis MN (2003) Oestrogen receptors in cultured epithelial cells from salivary glands of Sjögren’s syndrome patients. Rheumatology (Oxford) 42:1120–1122CrossRef
32.
go back to reference Valimaa H, Savolainen S, Soukka T et al (2004) Estrogen receptor-beta is the predominant estrogen receptor subtype in human oral epithelium and salivary glands. J Endocrinol 180:55–62PubMedCrossRef Valimaa H, Savolainen S, Soukka T et al (2004) Estrogen receptor-beta is the predominant estrogen receptor subtype in human oral epithelium and salivary glands. J Endocrinol 180:55–62PubMedCrossRef
33.
go back to reference Shim GJ, Warner M, Kim HJ et al (2004) Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjögren’s syndrome. Proc Natl Acad Sci USA 101:12628–12633PubMedCrossRef Shim GJ, Warner M, Kim HJ et al (2004) Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjögren’s syndrome. Proc Natl Acad Sci USA 101:12628–12633PubMedCrossRef
34.
go back to reference Ishimaru N, Arakaki R, Omotehara F et al (2006) Novel role for RbAp48 in tissue-specific, estrogen deficiency-dependent apoptosis in the exocrine glands. Mol Cell Biol 26:2924–2935PubMedCrossRef Ishimaru N, Arakaki R, Omotehara F et al (2006) Novel role for RbAp48 in tissue-specific, estrogen deficiency-dependent apoptosis in the exocrine glands. Mol Cell Biol 26:2924–2935PubMedCrossRef
35.
go back to reference Ishimaru N, Arakaki R, Yoshida S, Yamada A, Noji S, Hayashi Y (2008) Expression of the retinoblastoma protein RbAp48 in exocrine glands leads to Sjögren’s syndrome-like autoimmune exocrinopathy. J exp med 205:2915–2927PubMedCrossRef Ishimaru N, Arakaki R, Yoshida S, Yamada A, Noji S, Hayashi Y (2008) Expression of the retinoblastoma protein RbAp48 in exocrine glands leads to Sjögren’s syndrome-like autoimmune exocrinopathy. J exp med 205:2915–2927PubMedCrossRef
36.
go back to reference Arakaki R, Ishimaru N, Hayashi Y (2010) Immunotherapeutic targets in estrogen deficiency-dependent Sjögren’s syndrome-related manifestations. Immunotherapy 2:339–346PubMedCrossRef Arakaki R, Ishimaru N, Hayashi Y (2010) Immunotherapeutic targets in estrogen deficiency-dependent Sjögren’s syndrome-related manifestations. Immunotherapy 2:339–346PubMedCrossRef
37.
go back to reference Groom J, Kalled SL, Cutler AH et al (2002) Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren’s syndrome. J Clin Invest 109:59–68PubMed Groom J, Kalled SL, Cutler AH et al (2002) Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren’s syndrome. J Clin Invest 109:59–68PubMed
38.
go back to reference Batten M, Groom J, Cachero TG et al (2000) BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med 192:1453–1466PubMedCrossRef Batten M, Groom J, Cachero TG et al (2000) BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med 192:1453–1466PubMedCrossRef
39.
go back to reference Fletcher CA, Sutherland AP, Groom JR et al (2006) Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells. Eur J Immunol 36:2504–2514PubMedCrossRef Fletcher CA, Sutherland AP, Groom JR et al (2006) Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells. Eur J Immunol 36:2504–2514PubMedCrossRef
40.
go back to reference Qian Y, Qin J, Cui G et al (2004) Act1, a negative regulator in CD40- and BAFF-mediated B cell survival. Immunity 21:575–587PubMedCrossRef Qian Y, Qin J, Cui G et al (2004) Act1, a negative regulator in CD40- and BAFF-mediated B cell survival. Immunity 21:575–587PubMedCrossRef
41.
go back to reference Qian Y, Giltiay N, Xiao J et al (2008) Deficiency of Act1, a critical modulator of B cell function, leads to development of Sjögren’s syndrome. Eur J Immunol 38:2219–2228PubMedCrossRef Qian Y, Giltiay N, Xiao J et al (2008) Deficiency of Act1, a critical modulator of B cell function, leads to development of Sjögren’s syndrome. Eur J Immunol 38:2219–2228PubMedCrossRef
42.
go back to reference Ambrus JL Jr, Pippin J, Joseph A et al (1993) Identification of a cDNA for a human high-molecular-weight B-cell growth factor. Proc Natl Acad Sci USA 90:6330–6334PubMedCrossRef Ambrus JL Jr, Pippin J, Joseph A et al (1993) Identification of a cDNA for a human high-molecular-weight B-cell growth factor. Proc Natl Acad Sci USA 90:6330–6334PubMedCrossRef
43.
go back to reference Shen L, Suresh L, Li H et al (2009) IL-14 alpha, the nexus for primary Sjögren’s disease in mice and humans. Clin Immunol 130:304–312PubMedCrossRef Shen L, Suresh L, Li H et al (2009) IL-14 alpha, the nexus for primary Sjögren’s disease in mice and humans. Clin Immunol 130:304–312PubMedCrossRef
44.
go back to reference Shen L, Zhang C, Wang T et al (2006) Development of autoimmunity in IL-14alpha-transgenic mice. J Immunol 177:5676–5686PubMed Shen L, Zhang C, Wang T et al (2006) Development of autoimmunity in IL-14alpha-transgenic mice. J Immunol 177:5676–5686PubMed
45.
go back to reference Shen L, Suresh L, Wu J et al (2010) A role for lymphotoxin in primary Sjögren’s disease. J Immunol 185:6355–6363PubMedCrossRef Shen L, Suresh L, Wu J et al (2010) A role for lymphotoxin in primary Sjögren’s disease. J Immunol 185:6355–6363PubMedCrossRef
46.
go back to reference Nguyen CQ, Sharma A, Lee BH, She JX, Mcindoe RA, Peck AB (2009) Differential gene expression in the salivary gland during development and onset of xerostomia in Sjögren’s syndrome-like disease of the C57BL/6.NOD-Aec1Aec2 mouse. Arthritis Res Ther 11:R56PubMedCrossRef Nguyen CQ, Sharma A, Lee BH, She JX, Mcindoe RA, Peck AB (2009) Differential gene expression in the salivary gland during development and onset of xerostomia in Sjögren’s syndrome-like disease of the C57BL/6.NOD-Aec1Aec2 mouse. Arthritis Res Ther 11:R56PubMedCrossRef
47.
go back to reference Hjelmervik TO, Petersen K, Jonassen I, Jonsson R, Bolstad AI (2005) Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren’s syndrome patients from healthy control subjects. Arthritis Rheum 52:1534–1544PubMedCrossRef Hjelmervik TO, Petersen K, Jonassen I, Jonsson R, Bolstad AI (2005) Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren’s syndrome patients from healthy control subjects. Arthritis Rheum 52:1534–1544PubMedCrossRef
48.
go back to reference Robinson CP, Brayer J, Yamachika S et al (1998) Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren’s syndrome. Proc Natl Acad Sci USA 95:7538–7543PubMedCrossRef Robinson CP, Brayer J, Yamachika S et al (1998) Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren’s syndrome. Proc Natl Acad Sci USA 95:7538–7543PubMedCrossRef
49.
go back to reference Nguyen CQ, Gao J-H, Kim H, Saban DR, Cornelius JG, Peck AB (2007) IL-4-STAT6 signal transduction-dependent induction of the clinical phase of Sjögren’s syndrome-like disease of the nonobese diabetic mouse. J Immunol 179:382–390PubMed Nguyen CQ, Gao J-H, Kim H, Saban DR, Cornelius JG, Peck AB (2007) IL-4-STAT6 signal transduction-dependent induction of the clinical phase of Sjögren’s syndrome-like disease of the nonobese diabetic mouse. J Immunol 179:382–390PubMed
50.
go back to reference Van Blokland SC, Versnel MA (2002) Pathogenesis of Sjögren’s syndrome: characteristics of different mouse models for autoimmune exocrinopathy. Clin Immunol 103:111–124PubMedCrossRef Van Blokland SC, Versnel MA (2002) Pathogenesis of Sjögren’s syndrome: characteristics of different mouse models for autoimmune exocrinopathy. Clin Immunol 103:111–124PubMedCrossRef
51.
go back to reference Scofield RH, Asfa S, Obeso D, Jonsson R, Kurien BT (2005) Immunization with short peptides from the 60-kDa Ro antigen recapitulates the serological and pathological findings as well as the salivary gland dysfunction of Sjögren’s syndrome. J Immunol 175:8409–8414PubMed Scofield RH, Asfa S, Obeso D, Jonsson R, Kurien BT (2005) Immunization with short peptides from the 60-kDa Ro antigen recapitulates the serological and pathological findings as well as the salivary gland dysfunction of Sjögren’s syndrome. J Immunol 175:8409–8414PubMed
52.
go back to reference Iizuka M, Wakamatsu E, Tsuboi H et al (2010) Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjögren’s syndrome-like sialoadenitis. J Autoimmun 35:383–389PubMedCrossRef Iizuka M, Wakamatsu E, Tsuboi H et al (2010) Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjögren’s syndrome-like sialoadenitis. J Autoimmun 35:383–389PubMedCrossRef
53.
go back to reference Bymaster FP, Mckinzie DL, Felder CC, Wess J (2003) Use of M1-M5 muscarinic receptor knockout mice as novel tools to delineate the physiological roles of the muscarinic cholinergic system. Neurochem Res 28:437–442PubMedCrossRef Bymaster FP, Mckinzie DL, Felder CC, Wess J (2003) Use of M1-M5 muscarinic receptor knockout mice as novel tools to delineate the physiological roles of the muscarinic cholinergic system. Neurochem Res 28:437–442PubMedCrossRef
54.
go back to reference Kurien BT, Asfa S, Li C, Dorri Y, Jonsson R, Scofield RH (2005) Induction of oral tolerance in experimental Sjögren’s syndrome autoimmunity. Scand J Immunol 61:418–425PubMedCrossRef Kurien BT, Asfa S, Li C, Dorri Y, Jonsson R, Scofield RH (2005) Induction of oral tolerance in experimental Sjögren’s syndrome autoimmunity. Scand J Immunol 61:418–425PubMedCrossRef
55.
go back to reference Ohlsson M, Jonsson R, Brokstad KA (2002) Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjögren’s syndrome. Scand J Immunol 56:456–469PubMedCrossRef Ohlsson M, Jonsson R, Brokstad KA (2002) Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjögren’s syndrome. Scand J Immunol 56:456–469PubMedCrossRef
56.
go back to reference Espinosa A, Dardalhon V, Brauner S et al (2009) Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway. J Exp Med 206:1661–1671PubMedCrossRef Espinosa A, Dardalhon V, Brauner S et al (2009) Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway. J Exp Med 206:1661–1671PubMedCrossRef
57.
go back to reference Dawson LJ, Fox PC, Smith PM (2006) Sjögrens syndrome—the non-apoptotic model of glandular hypofunction. Rheumatology (Oxford) 45:792–798CrossRef Dawson LJ, Fox PC, Smith PM (2006) Sjögrens syndrome—the non-apoptotic model of glandular hypofunction. Rheumatology (Oxford) 45:792–798CrossRef
58.
go back to reference Soyfoo MS, Steinfeld S, Delporte C (2007) Usefulness of mouse models to study the pathogenesis of Sjögren’s syndrome. Oral Dis 13:366–375PubMedCrossRef Soyfoo MS, Steinfeld S, Delporte C (2007) Usefulness of mouse models to study the pathogenesis of Sjögren’s syndrome. Oral Dis 13:366–375PubMedCrossRef
59.
go back to reference Sakai A, Sugawara Y, Kuroishi T, Sasano T, Sugawara S (2008) Identification of IL-18 and Th17 cells in salivary glands of patients with Sjögren’s syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. J Immunol 181:2898–2906PubMed Sakai A, Sugawara Y, Kuroishi T, Sasano T, Sugawara S (2008) Identification of IL-18 and Th17 cells in salivary glands of patients with Sjögren’s syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. J Immunol 181:2898–2906PubMed
60.
go back to reference Nguyen CQ, Hu MH, Li Y, Stewart C, Peck AB (2008) Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren’s syndrome: findings in humans and mice. Arthritis Rheum 58:734–743PubMedCrossRef Nguyen CQ, Hu MH, Li Y, Stewart C, Peck AB (2008) Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren’s syndrome: findings in humans and mice. Arthritis Rheum 58:734–743PubMedCrossRef
61.
go back to reference Katsifis GE, Rekka S, Moutsopoulos NM, Pillemer S, Wahl SM (2009) Systemic and local interleukin-17 and linked cytokines associated with Sjögren’s syndrome immunopathogenesis. Am J Pathol 175:1167–1177PubMedCrossRef Katsifis GE, Rekka S, Moutsopoulos NM, Pillemer S, Wahl SM (2009) Systemic and local interleukin-17 and linked cytokines associated with Sjögren’s syndrome immunopathogenesis. Am J Pathol 175:1167–1177PubMedCrossRef
63.
go back to reference Bain G, Cravatt CB, Loomans C, Alberola-Ila J, Hedrick SM, Murre C (2001) Regulation of the helix-loop-helix proteins, E2A and Id3, by the Ras-ERK MAPK cascade. Nat Immunol 2:165–171PubMedCrossRef Bain G, Cravatt CB, Loomans C, Alberola-Ila J, Hedrick SM, Murre C (2001) Regulation of the helix-loop-helix proteins, E2A and Id3, by the Ras-ERK MAPK cascade. Nat Immunol 2:165–171PubMedCrossRef
64.
go back to reference Pan L, Sato S, Frederick JP, Sun XH, Zhuang Y (1999) Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene. Mol Cell Biol 19:5969–5980PubMed Pan L, Sato S, Frederick JP, Sun XH, Zhuang Y (1999) Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene. Mol Cell Biol 19:5969–5980PubMed
65.
go back to reference Li H, Dai M, Zhuang Y (2004) A T cell intrinsic role of Id3 in a mouse model for primary Sjögren’s syndrome. Immunity 21:551–560PubMedCrossRef Li H, Dai M, Zhuang Y (2004) A T cell intrinsic role of Id3 in a mouse model for primary Sjögren’s syndrome. Immunity 21:551–560PubMedCrossRef
66.
go back to reference Guo Z, Li H, Han M, Xu T, Wu X, Zhuang Y (2011) Modeling Sjögren’s syndrome with Id3 conditional knockout mice. Immunol Lett 135:34–42PubMedCrossRef Guo Z, Li H, Han M, Xu T, Wu X, Zhuang Y (2011) Modeling Sjögren’s syndrome with Id3 conditional knockout mice. Immunol Lett 135:34–42PubMedCrossRef
67.
go back to reference Hayakawa I, Tedder TF, Zhuang Y (2007) B-lymphocyte depletion ameliorates Sjögren’s syndrome in Id3 knockout mice. Immunology 122:73–79PubMedCrossRef Hayakawa I, Tedder TF, Zhuang Y (2007) B-lymphocyte depletion ameliorates Sjögren’s syndrome in Id3 knockout mice. Immunology 122:73–79PubMedCrossRef
68.
go back to reference Sellam J, Miceli-Richard C, Gottenberg JE et al (2008) Is inhibitor of differentiation 3 involved in human primary Sjögren’s syndrome? Rheumatology (Oxford) 47:437–441CrossRef Sellam J, Miceli-Richard C, Gottenberg JE et al (2008) Is inhibitor of differentiation 3 involved in human primary Sjögren’s syndrome? Rheumatology (Oxford) 47:437–441CrossRef
69.
go back to reference Fayard E, Moncayo G, Hemmings BA, Hollander GA (2010) Phosphatidylinositol 3-kinase signaling in thymocytes: the need for stringent control. Sci Signal 3:re5PubMedCrossRef Fayard E, Moncayo G, Hemmings BA, Hollander GA (2010) Phosphatidylinositol 3-kinase signaling in thymocytes: the need for stringent control. Sci Signal 3:re5PubMedCrossRef
70.
go back to reference Garcon F, Patton DT, Emery JL et al (2008) CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer. Blood 111:1464–1471PubMedCrossRef Garcon F, Patton DT, Emery JL et al (2008) CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer. Blood 111:1464–1471PubMedCrossRef
71.
go back to reference Oak JS, Deane JA, Kharas MG et al (2006) Sjögren’s syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase. Proc Natl Acad Sci USA 103:16882–16887PubMedCrossRef Oak JS, Deane JA, Kharas MG et al (2006) Sjögren’s syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase. Proc Natl Acad Sci USA 103:16882–16887PubMedCrossRef
72.
73.
go back to reference Hooks JJ, Moutsopoulos HM, Geis SA, Stahl NI, Decker JL, Notkins AL (1979) Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med 301:5–8PubMedCrossRef Hooks JJ, Moutsopoulos HM, Geis SA, Stahl NI, Decker JL, Notkins AL (1979) Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med 301:5–8PubMedCrossRef
74.
go back to reference Boumba D, Skopouli FN, Moutsopoulos HM (1995) Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren’s syndrome. Br J Rheumatol 34:326–333PubMedCrossRef Boumba D, Skopouli FN, Moutsopoulos HM (1995) Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren’s syndrome. Br J Rheumatol 34:326–333PubMedCrossRef
75.
go back to reference Gao J, Killedar S, Cornelius JG, Nguyen C, Cha S, Peck AB (2006) Sjögren’s syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease. J Autoimmun 26:90–103PubMedCrossRef Gao J, Killedar S, Cornelius JG, Nguyen C, Cha S, Peck AB (2006) Sjögren’s syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease. J Autoimmun 26:90–103PubMedCrossRef
76.
go back to reference Nguyen CQ, Yin H, Lee BH, Chiorini JA, Peck AB (2011) IL17: potential therapeutic target in Sjögren’s syndrome using adenovirus-mediated gene transfer. Lab Invest 91(1):54–62 Nguyen CQ, Yin H, Lee BH, Chiorini JA, Peck AB (2011) IL17: potential therapeutic target in Sjögren’s syndrome using adenovirus-mediated gene transfer. Lab Invest 91(1):54–62
77.
go back to reference Nguyen CQ, Yin H, Lee BH, Carcamo WC, Chiorini JA, Peck AB (2010) Pathogenic effect of interleukin-17A in induction of Sjögren’s syndrome-like disease using adenovirus-mediated gene transfer. Arthritis Res Ther 12:R220PubMedCrossRef Nguyen CQ, Yin H, Lee BH, Carcamo WC, Chiorini JA, Peck AB (2010) Pathogenic effect of interleukin-17A in induction of Sjögren’s syndrome-like disease using adenovirus-mediated gene transfer. Arthritis Res Ther 12:R220PubMedCrossRef
78.
go back to reference Hsu HC, Yang P, Wang J et al (2008) Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 9:166–175PubMedCrossRef Hsu HC, Yang P, Wang J et al (2008) Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 9:166–175PubMedCrossRef
Metadata
Title
Animal Models in Autoimmune Diseases: Lessons Learned from Mouse Models for Sjögren’s Syndrome
Authors
Byung Ha Lee
Adrienne E. Gauna
Kaleb M. Pauley
Yun-Jong Park
Seunghee Cha
Publication date
01-02-2012
Publisher
Humana Press Inc
Published in
Clinical Reviews in Allergy & Immunology / Issue 1/2012
Print ISSN: 1080-0549
Electronic ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-011-8288-5

Other articles of this Issue 1/2012

Clinical Reviews in Allergy & Immunology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine